Is finasteride really safe? The debate continues

The safety of finasteride, a 5-alpha reductase inhibitor, has been the subject of considerable debate in the medical community. Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and androgenic alopecia (AGA) and is generally considered to have a favorable safety profile. Long-term studies, such as those conducted by Shin et al., show that 98.4% of patients experienced improvements in AGA after five years of treatment, suggesting that finasteride can effectively manage this condition (Shin et al., 2018).

Side effects: a shadow over its use in young people

Concerns remain about its long-term safety, especially in younger populations. Chiriacò et al. conducted an observational study that highlighted the potential for serious adverse effects even at low doses, which has raised concerns about its use in young men (Chiriacò et al., 2016). Other studies have also reported sexual side effects, such as erectile dysfunction and decreased libido, although these are usually reversible upon discontinuation of the drug (Sorbellini et al., 2018). However, the psychological impact of these adverse effects may raise concerns for patients considering long-term treatment (Chandrashekar et al., 2015).

Finasteride vs. other options: are there safer alternatives?

The comparative safety of finasteride versus other treatments for AGA has also been the subject of study. Choi et al. found that the safety profiles of dutasteride and finasteride were largely equivalent, although some studies suggest that dutasteride might offer additional benefits in certain patients (Choi et al., 2022). This raises the possibility that there may be alternative treatments that may mitigate the risks associated with finasteride. Research by Sato and Takeda supports the idea that long-term treatment with finasteride may provide long-lasting improvements in hair growth, but also emphasizes the need for careful patient selection and ongoing monitoring (Sato & Takeda, 2011).

Hormonal impact: beyond hair growth

The systemic effects of finasteride, especially on hormonal balance, deserve attention. A systematic review by Hu et al. indicated that finasteride might affect hormonal levels, especially in women, where it has been used to treat conditions such as hirsutism and polycystic ovary syndrome (Hu et al., 2019). This highlights the importance of understanding the broader implications of finasteride therapy, beyond its primary indications. Furthermore, although the incidence of sexual side effects is relatively low, they may be significant enough to affect a patient's quality of life. Ganzer et al. documented persistent sexual, emotional, and cognitive dysfunctions following finasteride use (Ganzer et al., 2014).

The power of the mind: the nocebo effect in side effects

The psychological component of finasteride side effects cannot be overlooked. Research by Mondaini et al. suggests that the nocebo phenomenon—when patients experience side effects due to their expectations rather than the direct pharmacological action—might influence reports of sexual dysfunction associated with finasteride (Mondaini et al., 2007). This underscores the importance of patient education and counseling prior to initiating treatment, as well as ongoing support during use.

Persistent effects? Concerns about long-term use

The possibility of persistent side effects has led to increasing scrutiny of finasteride's long-term safety. Irwig's research on long-term sexual side effects raises critical questions about the permanence of these adverse effects and their underlying mechanisms (Irwig, 2012). This is especially concerning for patients who may not have been adequately informed about the risks associated with its long-term use. The findings highlight the need for a more cautious approach when prescribing finasteride, especially in younger patients who might be more susceptible to these effects.

Conclusion: An effective drug, but with caveats In summary, although finasteride is generally considered safe and effective for the treatment of BPH and AGA, the potential for adverse effects, particularly sexual dysfunction, remains a major concern. Evidence suggests that while most patients tolerate the drug well, a subset might experience serious side effects that affect their quality of life. Therefore, finasteride prescribers should be cautious about the use of finasteride.

References: <br>Chandrashekar, B., Nandhini, T., Vasanth, V., Sriram, R., & Navale, S. (2015). Topical minoxidil fortified with finasteride: an account of maintenance of hair density after replacing oral finasteride. Indian Dermatology Online Journal, 6(1), 17. https://doi.org/10.4103/2229-5178.148925<br>Chiriacò, G., Cauci, S., Mazzon, G., & Trombetta, C. (2016). An observational retrospective evaluation of 79 young men with long‐term adverse effects after use of finasteride against androgenetic alopecia. Andrology, 4(2), 245-250. https://doi.org/10.1111/andr.12147<br>Choi, G., Sim, W., Kang, H., Huh, C., Lee, Y., Shantakumar, S., … & Ong, G. (2022). Long-term effectiveness and safety of dutasteride versus finasteride in patients with male androgenic alopecia in south korea: a multicentre chart review study. Annals of Dermatology, 34(5), 349. https://doi.org/10.5021/ad.22.027<br>Ganzer, C., Jacobs, A., & Iqbal, F. (2014). Persistent sexual, emotional, and cognitive impairment post-finasteride. American Journal of Men S Health, 9(3), 222-228. https://doi.org/10.1177/1557988314538445<br>Hu, A., Chapman, L., & Mesinkovska, N. (2019). The efficacy and use of finasteride in women: a systematic review. International Journal of Dermatology, 58(7), 759-776. https://doi.org/10.1111/ijd.14370<br>Irwig, M. (2012). Persistent sexual side effects of finasteride: could they be permanent?. Journal of Sexual Medicine, 9(11), 2927-2932. https://doi.org/10.1111/j.1743-6109.2012.02846.x<br>Moisseiev, E., Holmes, A., Moshiri, A., & Morse, L. (2016). Finasteride is effective for the treatment of central serous chorioretinopathy. Eye, 30(6), 850-856. https://doi.org/10.1038/eye.2016.53<br>Mondaini, N., Gontero, P., Giubilei, G., Lombardi, G., Cai, T., Gavazzi, A., … & Bartoletti, R. (2007). Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?. Journal of Sexual Medicine, 4(6), 1708-1712. https://doi.org/10.1111/j.1743-6109.2007.00563.x<br>Sato, A. and Takeda, A. (2011). Evaluation of efficacy and safety of finasteride 1 mg in 3177 japanese men with androgenetic alopecia. The Journal of Dermatology, 39(1), 27-32. https://doi.org/10.1111/j.1346-8138.2011.01378.x<br>Shin, J., Chung, E., Kim, M., Kim, T., Kim, W., & Huh, C. (2018). Evaluation of long‐term efficacy of finasteride in korean men with androgenetic alopecia using the basic and specific classification system. The Journal of Dermatology, 46(2), 139-143. https://doi.org/10.1111/1346-8138.14719<br>Sorbellini, E., Pinto, D., Mora, B., & Rinaldi, F. (2018). Drug treatment for androgenetic alopecia: first italian questionnaire survey on what dermatologists think about finasteride. Dermatology and Therapy, 8(2), 259-267. https://doi.org/10.1007/s13555-018-0233-6</p>